Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran ; volume:13 ; number:1 ; day:4 ; month:9 ; year:2023 ; pages:1-11 ; date:12.2023
Health economics review ; 13, Heft 1 (4.9.2023), 1-11, 12.2023
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13561-023-00457-4
- URN
-
urn:nbn:de:101:1-2023111411203970699240
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ravangard, Ramin
- Jalali, Farideh Sadat
- Hajahmadi, Marjan
- Jafari, Abdosaleh
- SpringerLink (Online service)
Ähnliche Objekte (12)
A telemonitoring programme in patients with heart failure in France: a cost-utility analysis
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Cost–utility analysis of a palliative care program in Colombia
Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea
Practical guidance on the use of sacubitril/valsartan for heart failure
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
A cost-utility analysis of multimodal pain rehabilitation in primary healthcare
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
Cost-utility analysis of add-on vericiguat for the treatment of chronic heart failure with reduced ejection fraction in China
A telemonitoring programme in patients with heart failure in France: a cost-utility analysis
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Cost–utility analysis of a palliative care program in Colombia
Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea
Practical guidance on the use of sacubitril/valsartan for heart failure
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
A cost-utility analysis of multimodal pain rehabilitation in primary healthcare
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
Cost-utility analysis of add-on vericiguat for the treatment of chronic heart failure with reduced ejection fraction in China
A telemonitoring programme in patients with heart failure in France: a cost-utility analysis
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Cost–utility analysis of a palliative care program in Colombia
Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea
Practical guidance on the use of sacubitril/valsartan for heart failure
Economic efficiency and QALY-based cost-utility analysis in health care
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
A cost-utility analysis of multimodal pain rehabilitation in primary healthcare
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis